Worth Venture Partners, LLC Cognition Therapeutics Inc Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.56 - $3.38 $10,920 - $23,660
7,000 Added 1.4%
508,719 $930,000
Q4 2022

Feb 14, 2023
BUY
$1.17 - $3.51 $352,791 - $1.06 Million
301,531 Added 150.62%
501,719 $1.05 Million
Q3 2022

Nov 14, 2022
SELL
$1.63 - $3.6 $45,610 - $100,735
-27,982 Reduced 12.26%
200,188 $380,000
Q2 2022

Aug 15, 2022
BUY
$1.5 - $3.45 $79,206 - $182,173
52,804 Added 30.11%
228,170 $459,000
Q1 2022

May 16, 2022
BUY
$2.41 - $6.9 $422,632 - $1.21 Million
175,366 New
175,366 $473,000

Others Institutions Holding CGTX

# of Institutions
44
Shares Held
6.52M
Call Options Held
0
Put Options Held
0
View Full List

About COGNITION THERAPEUTICS INC

CGTX Quotes by TradingView
  • Ticker CGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,710,700
  • Market Cap $9.99M
  • Description
  • Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...
More about CGTX
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email